The invention relates to a new and improved “frameless” copper-releasing or hormone-releasing intrauterine contraceptive device or system (IUD/IUS).
The known frameless copper intrauterine device, called GyneFix®, has six copper tubes, each 5 mm long and 2.2 mm wide, threaded on a length of thread or suture material. This was generally disclosed in U.S. Pat. No. 4,708,134 or EP 0191747. The proximal end of the device is provided with an anchoring means for its fixation to the uterine wall in order to prevent that the device is pushed out by the uterus.
Another known device or system is the frameless hormone-releasing FibroPlant® which is similar to the GyneFix® IUD but instead of copper cylinders, as the active component, is provided with a fiber or several fibers or loops held together in one assembly zone, and which releases the hormone in the uterine cavity. The hormone, such as steroid hormone, is a contraceptive and/or a therapeutic agent. An anchoring means similar to the above mentioned one is also provided for its fixation in the uterine wall. This was generally disclosed in U.S. Pat. No. 5,433,218 or EP0445150.
These devices are remarkably well tolerated by any uterus, irrespective of its size and shape, due to the absence of a rigid frame, which eliminates dimensional incompatibility with the uterine cavity.
In order to retain the IUD/IUS in the uterine cavity, there is therefore a means to suspend the device to prevent its expulsion from the uterus. The preferred means is to suspend the IUD or IUS in the uterine cavity simply by providing a knot in the anchoring thread and then pushing such in the wall of the uterus by means of an applicator comprising, for example, a stylet-tip cooperating with a small loop extending from the knot.
A knot in the context of the present invention consists of a location of the thread were the thread has been deformed and/or multiply folded in such a way to produce a localised stable mass or lump of thread comprising at least a loop extending from this mass in order to provide a way for a hooking point of a stylet-tip during the insertion process. The mass of thread may be produced by intertwining and/or its stability enhanced by local fusion of the thread which is made at least partially of thermoplastic component. The dimension of the knot is larger than the diameter of the thread, for example 3 to 6 times larger, typically between 0.8 and 2.0 mm. The proximal end of the thread becomes a short appendix extending from the knot. The knot or deformation in the thread is small in volume and of a form suitable to allow its withdrawal under the effect of sufficient pulling, form the tissue of the uterus without damaging the latter.
Both active substances, copper and the hormone-releasing fibrous delivery system, can be visualized and their position in the uterine cavity can be checked by ultrasound.
The anchor in the tissue however cannot be visualized, or insufficiently, in many instances. The proper position of the anchor in the wall of the uterus is extremely important as the performance of the IUD/IUS depends on it. It can become expelled or the anchor can be inserted too deep, perforating the wall of the uterus. Perforation of the uterus is a serious adverse event which can lead to pain complaints, infection in the abdomen and pregnancy as there is no protection anymore if the IUD/IUS is not in situ.
In order to solve this problem and make it possible for the doctor to check the correct position of the anchor, according to the invention, a means has been provided to visualize the anchoring knot.
According to a preferred embodiment of the invention, there is indeed threaded a tiny metal tube on the anchoring thread immediately below the anchoring knot. Studies have shown that steel is more echogenic on ultrasound than copper and therefore the stainless steel tube can be kept extremely small. It is also important that the right material is used as the material should be biocompatible because the tiny steel tube will remain in the uterine wall for months or years until the IUD/IUS is removed.
It has been surprisingly found that this tiny metal tube in the fundus is well tolerated and does not affect the other properties of the frameless IUD/IUS.
Another aspect of the current improvement to frameless copper devices is related to the size of the copper elements loaded onto the IUD.
The abovementioned device known as GyneFix® comprises copper cylinders and is very efficient as the inner surface of the copper cylinders is in contact with the uterine environment, thereby increasing the effective copper surface area, as there is no plastic frame. This, as mentioned, is different from other known copper IUDs.
This standard prior art “frameless” IUD has an effective copper surface area of approximately 330 mm2 and is a highly effective intrauterine contraceptive system. In randomized clinical trials, it has been shown to be more effective that the most effective copper IUD available on the market. In addition, with this IUD, because of its smaller size and flexibility, the effect on menstrual blood loss is reduced when compared with the larger, conventional copper-releasing IUDs.
An important drawback of IUDs is indeed their tendency to cause heavy, sometimes painful, menstrual bleeding. Heavy bleeding is the commonest cause for IUD discontinuation. Discontinuation rates for bleeding vary from 7.0 to 12.0 during the first year of use. In the USA, an estimate of 36% of IUD users terminate during the first year for reasons other than the desire for pregnancy, including heavy menstrual bleeding and pain. Heavy menstrual bleeding may have a deleterious effect on health among normally healthy women. This is especially the case in women living in deprived developing countries where increased menstrual blood loss may precipitate or aggravate iron deficiency anaemia. It has been reported that even minute increases in menstrual blood loss may adversely affect the health of women especially during long-term use of IUD contraception.
Anaemia is common according to a recent report of the WHO (World Health Organization). The incidence of anaemia in Western Europe and the USA is about 8%, in the other European countries about 20-30%, South America about 20-30%.
It has now been found that the use of a still reduced size of the contraceptive device produces surprisingly even less menstrual blood loss (MBL) than the already small frameless IUD previously known, with a copper surface area of about 330 mm2.
According to another aspect of the invention it has therefore been found that reducing the size of a device of the prior art further results in an intrauterine device which is surprisingly still highly reliable and efficient, due to its high effective copper surface area, and is well tolerated, with minimal effect on menstrual blood loss, because of its very small size.
According to still another aspect of the invention, an IUD device is provided with a means to increase the release of copper from the smaller device.
It is known that noble metals such as gold and silver can influence the release of copper. This effect has already been described in the patent document PCT/HU90/00009. The essence of this patent is that the active body is made of at least two metals forming a plurality of galvanic cells in the uterine environment and is accomplished by making an alloy or microscopic mixture of the different metals.
It has been shown that it is especially desirable to design a device of which the active substance is copper and to add at least one metal which has a higher electropositivity such as gold. The copper elements then form the anode and the gold the cathode of the galvanic cell. The uterine environment functions thereby as the electrolyte.
With the GyneFix®-type IUD of the present invention, the improvement is obtained not by providing an alloy or mixture but surprisingly it is simply accomplished by alternating copper cylinders with small gold cylinders, creating these galvanic cells. In this way, the device remains, as intended, highly flexible resulting in optimal tolerance by the patient.
Previous dissolution studies of the GyneFix® 330 IUD yielded a minimal dissolution rate, per copper tube, of 2.4 mg per year. The addition of gold increases the copper ion release in the uterine environment thereby enhancing the contraceptive effectiveness based on the increased inactivation of the spermatozoa.
The primary aim of the present invention is to provide a means to make the current anchor visible on ultrasound and x-ray to allow the provider to check if the anchor is properly placed in the wall of the uterus since the performance of the frameless IUD/IUS depends on correct placement of the anchor. The visualization of the anchor thereby significantly increases the safety of the anchoring concept.
This goal is reached by adding a tubular metal element to the anchor fixed onto the anchoring thread just below the anchoring knot and/or on the appendix of the anchoring knot.
If a tube is threaded on the anchoring thread, this method of realization does not hinder the anchor for suspending the copper IUD or of the hormone-releasing IUS when inserted with an applicator into the musculature of the uterine fundus.
According to a particular embodiment, the anchoring knot may also be treated with metal dust attached or incorporated in the material of the anchoring knot or deformation of the thread serving as anchor. In this case the anchoring knot is preferably created by heat deformation during which small particles of metal are added.
The secondary aim of the present invention is to provide a copper IUD to minimize the impact on menstrual blood loss. This device has a smaller total (nominal) surface area but a large effective copper surface area, when compared to the effective copper surface area of the high-load conventional copper IUDs.
According to one characteristic of the invention, the total surface area of the IUD does not exceed 275 mm2. According to one preferred embodiment it will not exceed 200 mm2.
According to an additional characteristic of the invention, the effective copper surface area equals the nominal copper surface area which should be at least 200 mm2.
According to yet another aspect of the invention, the components are copper cylinders and are not longer than 6 to 8 mm in order to allow easier direct contact between the inner surface of the cylinders and the uterine environment.
According to yet another characteristic of the invention, all copper cylinders are kept in place by two small copper clips, one above and one below the copper cylinders, crimped onto the anchoring thread. The clips may be cylinders identical to the copper cylinders but which have been crimped. The design of the device and the manufacturing process may therefore be simplified.
According to still another additional characteristic of the invention, the total length of the closely approximated copper elements of the IUD is not longer than 2.6 cm.
According to still another additional characteristic of the invention, the total length of the IUD is not longer than 3.0 cm when the copper elements are freely separated.
According to an embodiment, the hollow elements are separated from each other by a small space to enhance the contact between the inner part of the cylinders and the uterine environment.
According to yet another characteristic of the invention, the hollow elements are not larger than 3.0 mm in diameter in order to allow easy insertion in the uterine cavity.
According to another characteristic of the invention, the inner diameter of the hollow elements is at least 1.6 mm in diameter to allow a high total (inner and outer) effective copper surface area similar to high-load copper IUDs.
The number of elements may be between 2 and 10, preferably between 3 to 6. Particularly preferred is a structure comprising 4 cylindrical elements, each approximately 5 mm in length, in a row of which the first and last have been crimped onto the anchoring thread.
According to another aspect of the invention there is provided a way to increase the copper release to enhance the inactivation by the copper ions on the sperm cells which is the main mechanism of action of copper IUDs. As mentioned before, copper and gold (or silver) enter into an electrochemical reaction. An alloy of copper and noble metal (silver, gold) creates a multitude of local tiny galvanic (alkaline) batteries when in contact with the uterine environment (which serves as an electrolyte). Copper act as an anode, while the noble metals (Ag, Au) serve as cathode. The resulting weak electrical activity has a negative effect on sperm cell motility, capacitation and survival, while the foreign body reaction, also stimulated electrically, increases leucocyte infiltration in the endometrium and further increases the number of macrophages in the uterine cavity (enhanced spermicidal effect). Silver and gold ions, dissolved in trace quantities, exhibit in situ bactericidal and fungicidal effects (oligodynamic effects), which are expected to lessen the risk of pelvic inflammatory disease (infection).
With the frameless IUD, the use of metal alloys is less practical than to use tubular elements which can simply be treaded on the anchoring suture. In view of the above considerations, practically, gold tubes with length varying between 1.6 and 2.0 mm are added between the copper tubes of the small IUD (GyneFix® type) at three possible locations: first, below the first “crimped” copper tube; second, between the “loose” (noncrimped) copper tubes; and thirdly above the lower “crimped” copper tube.
According to particular embodiment at least one short 2.0-3.0 mm gold tube is crimped onto the suture thread, for example one above and/or one below the four copper tubes.
An additional purpose of the invention is to reduce the risk of expulsion in cases where the uterine wall is soft (e.g., postpartum) by the provision of biodegradable material added to the anchoring knot. This can be realized by putting a cap on the assembled anchoring knot. The cap covers preferably the upper part of the knot and leaves a loop extending therefrom for permitting the insertion process with an inserter. The biodegradable cap will degrade in weeks or a few months, leaving only the anchoring knot for retention of the contraceptive device in the uterine cavity at the time the uterus has involuted. Exemplary biodegradable material is a polylactide or polycaprolactone.
These and other characteristics of the invention will be more readily understood when referring to the description as well as the accompanying drawings which represent, merely by way of examples, several embodiments of the invention, and in which:
Referring now more particularly to
According to another characteristic of the invention, the metal tube 6 is threaded on the appendix 4 of the anchoring knot 5 as shown in
Referring now particularly to
Preferably the IUD is made of hollow elements of which the total surface area is at least two times smaller when compared to a well-known conventional IUD (TCu380A) as shown in
As shown in
The present invention discloses, among others, in a non limitative way:
The invention has been described and illustrated merely by way of examples which are in no way restrictive. Novel features can be taken separately or in any possible combination. More particularly the present invention discloses generally, separately or in any combination a frameless intrauterine device having
Number | Date | Country | Kind |
---|---|---|---|
PCT/EP2009/067709 | Dec 2009 | EP | regional |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP10/70434 | 12/21/2010 | WO | 00 | 8/24/2012 |